Advertisement
NIA grant helps establish Nevada exploratory Alzheimer’s Disease Research Center
Longitudinal study implicates a specific pathway in mild cognitive impairment stage
$2 million will enable preclinical dose and efficacy testing of “compound 3”
Mission centers on screening, prevention for at-risk women in their 30s to 60s
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Local population, deep expertise portend a center with high impact
Cleveland Clinic-developed “compound 3” begins testing in preclinical Alzheimer’s model
Third annual report shows shift toward prevention studies, disease-modifying therapies
Two career achievement awards prompt Dr. Jeffrey Cummings to look back — and ahead
Most substantial reversal of amyloid deposition in an animal study to date
Probing how insurers, employers will use information
Advertisement
Advertisement